Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Monthly injection that blocks and degrades the oestrogen receptor. | Aromatase inhibitor for breast cancer treatment and prevention. |
| Body system | Cancer | Cancer |
| Drug class | Selective oestrogen receptor degraders | Aromatase inhibitors |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | Hormone-receptor-positive advanced breast cancer | Breast cancer after menopause, Breast cancer prevention (high risk) |
| How it works | Blocks oestrogen from stimulating breast cancer cells. | Cuts oestrogen levels after menopause. |
| Starts working | Depends on the cancer and regimen | — |
| Half-life | About 40 days | About 50 hours |
| Typical adult dose | Dosed by your cancer team according to the treatment protocol. | 1 mg once a day. |
| Forms | Intramuscular injection | Tablet |
| Common side effects | Injection site pain, Hot flushes, Nausea, Tiredness, Joint pain | Hot flushes, Joint pain, Tiredness |
| Serious side effects | Liver enzyme rise, Allergic reaction, Bruising and bleeding at injection site | Bone thinning, Severe skin reactions (rare) |
| Don't take if | Pregnancy; Severe liver impairment | — |
| Alcohol | Usually no problem in moderation. No specific interaction. | — |
| Pregnancy | Usually avoidedAvoid. | Usually avoidedNot for use in pregnancy. |
| Breastfeeding | Usually avoidedAvoid. | — |
| In use since | — | 1995 |
| Brand names | United States: FaslodexUnited Kingdom: FaslodexIndia: Faslodex, Fulvestrant (generic) | United States: ArimidexUnited Kingdom: ArimidexIndia: Armotraz, Altraz |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H | — |
| ATC code | L02BA03 | L02BG03 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker